Chemical synthesis and characterization of silver-protected vasoactive intestinal peptide nanoparticles

Interleukin-6 as a key player in systemic inflammation and joint destruction

(2009) J.E. Fonseca et al.   AUTOIMMUNITY REVIEWS

Autophagy and neuropeptides at the crossroad for parasites: To survive or to die?

(2009) Jenny Campos-Salinas et al.   Autophagy

Inflammation and Cancer: IL-6 and STAT3 Complete the Link

(2009) Jacqueline Bromberg et al.   CANCER CELL

A cellular model of inflammation for identifying TNF-α synthesis inhibitors

(2009) David Tweedie et al.   JOURNAL OF NEUROSCIENCE METHODS

Nanostructured surfaces: cell engineering and cell biology

(2009) Matthew J Dalby   Nanomedicine

Role of nanobiotechnology in the development of personalized medicine

(2009) KK Jain   Nanomedicine

Multicolor imaging of lymphatic function with two nanomaterials: quantum dot-labeled cancer cells and dendrimer-based optical agents

(2009) Hisataka Kobayashi et al.   Nanomedicine

Nanoscale labels: nanoparticles and liposomes in the development of high-performance biosensors

(2009) Marta Bally et al.   Nanomedicine

NanoART, neuroAIDS and CNS drug delivery

(2009) Ari Nowacek et al.   Nanomedicine

Brain targeting PBCA nanoparticles and the blood–brain barrier

(2009) B Wilson   Nanomedicine

The bright side of the glial scar in CNS repair

(2009) Asya Rolls et al.   NATURE REVIEWS NEUROSCIENCE

Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death

(2008) M Delgado et al.   CELL DEATH AND DIFFERENTIATION

Freeze drying of peptide drugs self-associated with long-circulating, biocompatible and biodegradable sterically stabilized phospholipid nanomicelles

(2008) Sok Bee Lim et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Immune-based disorders: the challenges for translational immunology

(2008) David Pozo   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders

(2008) Per Anderson et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

The N-Terminal Parts of VIP and Antagonist PG97–269 Physically Interact with Different Regions of the Human VPAC1 Receptor

(2008) Emilie Ceraudo et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

VIP, From Gene to Behavior and Back: Summarizing my 25 Years of Research

(2008) Illana Gozes   JOURNAL OF MOLECULAR NEUROSCIENCE

Peptide-Based Probes for Cancer Imaging

(2008) J. C. Reubi et al.   JOURNAL OF NUCLEAR MEDICINE

Tiopronin monolayer-protected silver nanoparticles modulate IL-6 secretion mediated by Toll-like receptor ligands

(2008) Paula M Castillo et al.   Nanomedicine

Nanotoxicology and nanomedicine: making hard decisions

(2008) Igor Linkov et al.   Nanomedicine-Nanotechnology Biology and Medicine

Nanotechnology in biology: big collaborations for a small world

(2008) Nathan Blow   NATURE METHODS

Remyelination in the CNS: from biology to therapy

(2008) Robin J. M. Franklin et al.   NATURE REVIEWS NEUROSCIENCE

Vasoactive intestinal peptide inhibits cycloxygenase-2 expression in activated macrophages, microglia, and dendritic cells

(2007) Elena Gonzalez-Rey et al.   BRAIN BEHAVIOR AND IMMUNITY

The Vasoactive Intestinal Peptide (VIP) α-Helix Up to C Terminus Interacts with the N-Terminal Ectodomain of the Human VIP/Pituitary Adenylate Cyclase-Activating Peptide 1 Receptor: Photoaffinity, Molecular Modeling, and Dynamics

(2007) Emilie Ceraudo et al.   MOLECULAR ENDOCRINOLOGY